_:nc5dedf158f8d404a922976d48cbc88bcxb0
<http://schema.org/headline>
"Affimed Announces IND Clearance for a Phase 2 Clinical Trial Investigating AFM13 and AB-101 Combination Therapy"
<https://stocks.observer-reporter.com/observerreporter/article/gnwcq-2023-5-23-affimed-announces-ind-clearance-for-a-phase-2-clinical-trial-investigating-afm13-and-ab-101-combination-therapy>